FRA
GILD icon

Frank Rimerman Advisors’s Gilead Sciences GILD Stock Holding History

Frank Rimerman Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.89M Hold
35,105
– – 0.32% 52
2025
Q4 		$4.31M Buy
35,105
+84
+0.2% +$10.2K 0.27% 56
2025
Q3 		$3.89M Buy
35,021
+2,942
+9% +$334K 0.25% 63
2025
Q2 		$3.56M Sell
32,079
-685
-2% -$72.9K 0.24% 66
2025
Q1 		$3.67M Buy
32,764
+446
+1% +$46K 0.29% 53
2024
Q4 		$2.99M Buy
32,318
+232
+0.7% +$20.9K 0.22% 72
2024
Q3 		$2.69M Buy
32,086
+2,252
+8% +$172K 0.19% 90
2024
Q2 		$2.05M Buy
29,834
+29,185
+4,497% +$1.95M 0.14% 116
2024
Q1 		$47.5K Buy
649
+208
+47% +$16K 0.01% 129
2023
Q4 		$35.7K Buy
+441
New +$34.3K 0.01% 130

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Frank Rimerman Advisors's GILD Position: Q1 2026 in Review

Frank Rimerman Advisors held its Gilead Sciences (GILD) position steady in Q1 2026 at 35,105 shares worth $4.89M. The position accounts for 0.32% of the portfolio, ranked #52.

Frank Rimerman Advisors first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Frank Rimerman Advisors held 35,105 shares of Gilead Sciences worth $4.89M as of Q1 2026.
  • Frank Rimerman Advisors left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.32% of Frank Rimerman Advisors's portfolio in Q1 2026, its #52 holding.
  • Frank Rimerman Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.